Physician profile
Cy Stein
NPI 1871673350
$122,047.13
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90K · 2020: $26K · 2021: $6,041.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $98,307.07 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $9,528.29 | 2019-2020 | |
| Janssen Biotech, INC. | $5,643.88 | 2019-2020 | |
| Pfizer INC. | $3,830.71 | 2019-2020 | |
| Astellas Pharma US INC | $3,653.95 | 2020 | |
| Sarepta Therapeutics, INC. | $1,025.00 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $58.23 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cy Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.